Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

Hospital Saint Joseph

Status: Enrolling

Conditions: Non Metastatic Colorectal Cancer

Treatments: Diagnostic Test: IMMUNOSCORE®

Study type: Interventional

Funder types: Other

Identifiers

NCT04938986

PPC-IS

Details and patient eligibility

About

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age between 18 and 80 inclusive;
• histologically confirmed colon adenocarcinoma;
• having undergone a curative resection of stage I, II or III colorectal cancer;
• diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
• eligible to receive 6 months of adjuvant chemotherapy;
• having given free, informed and written consent;
• agreeing to the use of a tumor sample for research purposes;
• being affiliated to a social security system.

Exclusion criteria

• pregnant or breastfeeding women
• legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.
• history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
• person subject to a safeguard measure.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

IMMUNOSCORE®

Experimental group

Treatment:

Diagnostic Test: IMMUNOSCORE®